Modulation of peroxisomes abundance by argan oil and lipopolysaccharides in acyl-CoA oxidase 1-deficient fibroblasts — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
Modulation of peroxisomes abundance by argan oil and lipopolysaccharides in acyl-CoA oxidase 1-deficient fibroblasts
Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
,
Laboratoir de Biochimie et Neurosciences, Faculté des Sciences et Techniques, Université Hassan I, Settat, Morocco
,
Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
,
Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
,
Université de Bourgogne, Centre de Recherche INSERM, UMR866, Dijon, France
,
Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
,
Laboratoire de Recherche sur les Lipoprotéines et l’Athérosclérose, Faculté des Sciences Ben M’sik, Université Hassan II- Mohammedia, Casablanca, Morocco
,
INSERM and HMNO, CBP, CHRU Lille, Lille, France
,
Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
,
Laboratoir de Biochimie et Neurosciences, Faculté des Sciences et Techniques, Université Hassan I, Settat, Morocco
,
Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
1 Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
2 Laboratoir de Biochimie et Neurosciences, Faculté des Sciences et Techniques, Université Hassan I, Settat, Morocco
3 Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
4 Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
5 Université de Bourgogne, Centre de Recherche INSERM, UMR866, Dijon, France
6 Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
7 Laboratoire de Recherche sur les Lipoprotéines et l’Athérosclérose, Faculté des Sciences Ben M’sik, Université Hassan II- Mohammedia, Casablanca, Morocco
8 INSERM and HMNO, CBP, CHRU Lille, Lille, France
9 Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
10 Laboratoir de Biochimie et Neurosciences, Faculté des Sciences et Techniques, Université Hassan I, Settat, Morocco
11 Université de Bourgogne, Laboratoire BioPeroxIL EA7270, Dijon, France
Pseudo-neonatal adrenoleukodystrophy (P-NALD) is a neurodegenerative disorder caused by acyl-CoA oxidase 1 (ACOX1) deficiency with subsequent impairment of peroxisomal fatty acid β -oxidation, accumulation of very long chain fatty acids (VLCFAs) and strong reduction in perox isome abundance. Increase in peroxisome number has been previously suggested to improve peroxisomal disorders, and in this perspective, the present work was aimed at exploring whether modulation of peroxisomes abundance could be achieved in P-NALD fibroblasts. Here we showed that treatment with the natural Argan oil induced peroxisome proliferation in P-NALD fibroblasts. This induction was independent on activations of both nuclear receptor PPAR α and its coacti vator PGC-1 α . Lipopolysaccharides (LPS) treatment, which caused inflammation, induced also a peroxisome proliferation that, in contrast, was dependent on activations of PPAR α and PGC-1 α . By its ability to induce peroxisome proliferation, Argan oil is suggested to be of potential therapeutic use in patients with P-NALD.
Poll-The, B.T., et al. (1988) A new peroxisomal disorder with enlarged peroxisomes and a specific deficiency of acyl-CoA oxidase (pseudo-neonatal adrenoleukodystrophy). American Journal of Human Genetics, 42, 422-434.
Wanders, R.J. and Waterham, H.R. (2006) Peroxisomal disorders: the single peroxisomal enzyme deficiencies. Biochimica et Biophysica Acta, 1763, 1707-1720. doi:10.1016/j.bbamcr.2006.08.010
El Hajj, H.I. et al. (2012) The inflammatory response in acyl-CoA oxidase 1 deficiency (pseudoneonatal adreno-leukodystrophy). Endocrinology, 153, 2568-2575. doi:10.1210/en.2012-1137
Cherkaoui-Malki, M., et al. (2012) Hepatic steatosis and peroxisomal fatty acid beta-oxidation. Current Drug Metabolism, 13, 1412-1421. doi:10.2174/138920012803762765
Reddy, J.K. (2004) Peroxisome proliferators and peroxisome proliferator-activated receptor alpha: Biotic and xenobiotic sensing. American Journal of Pathology, 164, 2305-2321. doi:10.1073/pnas.1009176107
Delille, H.K., Alves, R. and Schrader, M. (2009) Biogenesis of peroxisomes and mitochondria: Linked by division. Histochemistry and Cell Bi-ology, 131, 441-446.
Girzalsky, W., Saffian, D. and Erd-mann, R. (2010) Per- oxisomal protein translocation. Biochimica et Biophysica Acta, 1803, 724-731.
Bagattin, A., Hugendubler, L. and Mueller, E. (2010) Transcriptional coacti-vator PGC-1α promotes peroxisomal remodeling and bioge-nesis. Proceedings of the Na- tional Academy of Sciences, 107, 20376-20381.
Cherkaoui-Malki, M., et al. (2001) Identi-fication of novel peroxisome proliferator-activated receptor alpha (PPARα) target genes in mouse liver using cDNA microarray analysis. Gene Expression, 9, 291-304.
Vluggens, A. and Reddy, J.K. (2012) Nuclear receptors and transcription factors in the development of fatty liver disease. Current Drug Metabolism, 13, 1422-1435. doi:10.2174/138920012803762710
Forman, B.M., Chen, J. and Evans, R.M. (1997) Hypol- ipidemic drugs, polyunsatu-rated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proceedings of the National Academy of Sciences, 94, 4312-4317. doi:10.1073/pnas.94.9.4312
Gottlicher, M., et al. (1992) Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor. Proceedings of the National Academy of Sciences, 89, 4653-4657. doi:10.1073/pnas.89.10.4653
Issemann, I. and Green, S. (1990) Activation of a member of the steroid hormone receptor superfamily by perox- isome proliferators. Nature, 347, 645-650. doi:10.1038/347645a0
Fan, C.Y., et al. (1998) Steatohe-patitis, spontaneous peroxisome proliferation and liver tumors in mice lacking peroxisomal fatty acyl-CoA oxidase. Implications for per- oxisome proliferator-activated receptor alpha natural lig- and metabolism. Journal of Biological Chemistry, 273, 15639-15645. doi:10.1074/jbc.273.25.15639
Huang, J., et al. (2011) Progressive endoplasmic reticulum stress contributes to hepatocarcinogenesis in fatty acyl-CoA oxidase 1-deficient mice. The American Jour- nal of Pathology, 179, 703-713. doi:10.1016/j.ajpath.2011.04.030
Vluggens, A., et al. (2010) Reversal of mouse Acyl-CoA oxidase 1 (ACOX1) null phenotype by human ACOX1b isoform [corrected]. Laboratory Investigation: A Journal of Technical Methods and Pathology, 90, 696-708.
Ferdinandusse, S., et al. (2007) Clinical, biochemical, and mutational spectrum of peroxisomal acyl-coenzyme A oxidase deficiency. Human Mutation, 28, 904-912. doi:10.1002/humu.20535
Wei, H., et al. (2000) Pharma-cological induction of peroxisomes in peroxisome biogenesis disorders. Annals of neurology, 47, 286-296. doi:10.1002/1531-8249(200003)47:3 3.0.CO;2-B
Paintlia, M.K., et al. (2008) Lipopolysaccha-ride-induced peroxisomal dysfunction exacerbates cerebral white matter injury: Attenuation by N-acetyl cysteine. Experimental Neurology, 210, 560-576. doi:10.1016/j.expneurol.2007.12.011
Baarine, M., et al. (2009) Peroxisomal and mitochondrial status of two murine oligodendrocytic cell lines (158N, 158JP): Potential models for the study of peroxisomal disorders associated with dysmyelination processes. Journal of Neurochemistry, 111, 119-131. doi:10.1111/j.1471-4159.2009.06311.x
Schrader, M., Krieglstein, K. and Fahimi, H. D. (1998) Tubular peroxisomes in HepG2 cells: Selective induction by growth factors and ara-chidonic acid. European Journal of Cell Biology, 75, 87-96. doi:10.1016/S0171-9335(98)80051-4
Savary, S., et al. (2012) Fatty acids-induced lipotoxicity and inflammation. Current Drug Metabolism, 13, 1358- 1370. doi:10.2174/138920012803762729
Gondcaille, C., et al. (2005) Phenylbutyrate up-regulates the adrenoleukodystro-phy-related gene as a nonclassical peroxisome proliferator. Journal of Cell Biology, 169, 93-104. doi:10.1083/jcb.200501036
Zhang, X., et al. (2006) Peroxisome proliferator-activated receptor alpha-independent pe-roxisome proliferation. Biochemical and Biophysical Research Communications, 346, 1307-1311. doi:10.1016/j.bbrc.2006.06.042
Gloerich, J., et al. (2005) A phytol-enriched diet induces changes in fatty acid metabolism in mice both via PPARα-dependent and -independent pathways. Journal of Lipid Research, 46, 716-726. doi:10.1194/jlr.M400337-JLR200
DeLuca, J.G., et al. (2000) Evidence for peroxisome proliferator-activated receptor (PPAR)α-independent peroxisome proliferation: Effects of PPARγ/delta-specific agonists in PPARαlphanull mice. Moecular Pharmacology, 58, 470-476.
Jia, Y., et al. 2003) Overexpression of peroxisome proliferator-activated recep-tor-alpha (PPARα)-regulated genes in liver in the absence of peroxisome proliferation in mice deficient in both L- and D-forms of enoyl-CoA hydra- tase/dehydrogenase enzymes of peroxisomal beta-oxidation system. Journal of Biological Chemistry, 278, 47232- 47239. doi:10.1074/jbc.M306363200
Contreras, M.A., et al. (2000) Endotoxin induces structure-function alterations of rat liver peroxisomes: Kupffer cells released factors as possible modulators. Hepatology, 31, 446-455. doi:10.1002/hep.510310226
Dhaunsi, G.S., Hanevold, C.D. and Singh, I. (1994) Im pairment of peroxisomal beta-oxidation system by endotoxin treatment. Molecular and Cellular Biochemistry, 135, 187-193. doi:10.1007/BF00926522
Khan, M., et al. (1998) Cyto-kine-induced accumulation of very long-chain fatty acids in rat C6 glial cells: Implication for X-adrenoleukodystrophy. Journal of neuro- chemistry, 71, 78-87. doi:10.1046/j.1471-4159.1998.71010078.x
Paintlia, M.K., et al. (2008) Modulation of peroxisome proliferator-activated receptoralpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures. Journal of Neurochemistry, 105, 956-970. doi:10.1111/j.1471-4159.2007.05199.x
Schilling, J., et al. (2011) Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxi-some proliferator-activated receptor gamma coactivator-1 signaling. Circulation: Heart Failure, 4, 474-482. doi:10.1161/CIRCHEARTFAILURE.110.959833